ABRIVI THERAPEUTICS Trademark

Trademark Overview


On Thursday, January 4, 2024, a trademark application was filed for ABRIVI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ABRIVI THERAPEUTICS trademark a serial number of 98341186. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, October 10, 2024. This trademark is owned by MAPS Public Benefit Corporation. The ABRIVI THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.

Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.
abrivi therapeutics

General Information


Serial Number98341186
Word MarkABRIVI THERAPEUTICS
Filing DateThursday, January 4, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPrescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.
Goods and ServicesMedical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 4, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLYKOS THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02111

Party NameMAPS Public Benefit Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHingham, MA 02043

Trademark Events


Event DateEvent Description
Thursday, January 4, 2024NEW APPLICATION ENTERED
Wednesday, April 3, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, April 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 23, 2024ASSIGNED TO EXAMINER
Thursday, October 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 31, 2024ASSIGNED TO EXAMINER
Wednesday, August 7, 2024ASSIGNED TO EXAMINER
Thursday, October 10, 2024NON-FINAL ACTION E-MAILED
Thursday, October 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED